BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1236035)

  • 1. Bioavailability: some pharmaceutical factors.
    Fowle AS
    Trans Med Soc Lond; 1975; 91():23-32. PubMed ID: 1236035
    [No Abstract]   [Full Text] [Related]  

  • 2. Gastrointestinal absorption II. Formulation factors affecting drug bioavailability.
    Blanchard J
    Am J Pharm Sci Support Public Health; 1978; 150(5):132-51. PubMed ID: 364993
    [No Abstract]   [Full Text] [Related]  

  • 3. [Biologic availability and "1st pass" effect of drugs].
    Rietbrock N; Keller F
    Fortschr Med; 1977 Jul; 95(28):1765-6, 1774-80. PubMed ID: 914146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of the starting materials on bioavailability of drugs].
    Bagnaresi P; Bulgarelli D; Calvi A; Ferrarini G
    Boll Chim Farm; 1973 Feb; 112(2):83-93. PubMed ID: 4719968
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug formulation and biologic availability.
    Poole JW
    Semin Drug Treat; 1971 Sep; 1(2):148-76. PubMed ID: 5153883
    [No Abstract]   [Full Text] [Related]  

  • 6. Keeping bioavailability in perspective.
    Schumacher GE
    Am J Hosp Pharm; 1973 Feb; 30(2):150-4. PubMed ID: 4690469
    [No Abstract]   [Full Text] [Related]  

  • 7. [Biopharmaceutics and drug formulation].
    Riccieri FM
    Ann Ist Super Sanita; 1982; 18(3):541-6. PubMed ID: 7187842
    [No Abstract]   [Full Text] [Related]  

  • 8. Some factors affecting bioavailability of drug products.
    Lach JL
    J Iowa Med Soc; 1972 Aug; 62(8):441-2 passim. PubMed ID: 5044776
    [No Abstract]   [Full Text] [Related]  

  • 9. The formulation of aspirin.
    Martin BK
    Adv Pharm Sci; 1971; 3():107-71. PubMed ID: 4947388
    [No Abstract]   [Full Text] [Related]  

  • 10. Bioavailability of drugs (first of two parts).
    Koch-Weser J
    N Engl J Med; 1974 Aug; 291(5):233-7. PubMed ID: 4600408
    [No Abstract]   [Full Text] [Related]  

  • 11. A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system.
    Dokoumetzidis A; Macheras P
    Int J Pharm; 2006 Sep; 321(1-2):1-11. PubMed ID: 16920290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacology and practical therapy. Principles for the selection of application form of a drug and its mode of origin].
    Levy G; Barr WH
    Internist (Berl); 1973 Dec; 14(12):661-7. PubMed ID: 4593013
    [No Abstract]   [Full Text] [Related]  

  • 13. Implication of biopharmaceutics and pharmacokinetics of rifampicin in variable bioavailability from solid oral dosage forms.
    Agrawal S; Panchagnula R
    Biopharm Drug Dispos; 2005 Nov; 26(8):321-34. PubMed ID: 16059874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The general problem of drug bioavailability and its assessment in man.
    Smith RN
    Postgrad Med J; 1974 Nov; 50 Suppl 6():7-14. PubMed ID: 4459894
    [No Abstract]   [Full Text] [Related]  

  • 15. [Formulation of tablets and bioavailability: a biologic method of evaluation].
    Lévy-Appert-Collin M; Willemin JC; Lévy J
    Pharm Acta Helv; 1976; 51(11):348-51. PubMed ID: 1019179
    [No Abstract]   [Full Text] [Related]  

  • 16. [Differentiation of the degree of bioavailability of peroral drug forms of tetracycline hydrochloride in experiments on laboratory animals].
    Zak AF; Ermolova OB
    Antibiotiki; 1976 Feb; 21(2):151-5. PubMed ID: 1275466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biopharmaceutical investigations of rectal suppositories. Part 1: Pharmaceutical and biological availability of theophylline.
    Minkov E; Lambov N; Kirchev D; Bantutova I; Tencheva J
    Pharmazie; 1984 Apr; 39(4):242-3. PubMed ID: 6547533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms.
    Akers MJ
    Int J Pharm Compd; 2017; 21(1):47-56. PubMed ID: 28346198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The physiologic availability of solid dosage forms of phenylbutazone. II. Correlation of in vivo physiologic availability and in vitro dissolution parameters.
    Withey RJ; Feng H; Cook D; Van Petten GR; Lettau HF
    J Clin Pharmacol New Drugs; 1971; 11(3):187-96. PubMed ID: 5211352
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative biopharmaceutical study of tegalide].
    Lopatina NB; Lebedeva MN
    Med Parazitol (Mosk); 2000; (1):27-9. PubMed ID: 10808715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.